$VTGN

$0.17 -$0.01 (3.28%) Close

$VTGN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 44.4M shares outstanding

Who owns VTGN?

By type of holder

Institutions 26.5% Insiders 0.5% Everyone else 73.0%

Concentration Top 10 holders own 20.1%

Commodore Capital LP 6.3% · Vanguard Capital Management LLC 3.6%

Institutional ownership

26.5%

-6.7 pts vs last qtr

Institutional holders

-8 vs last qtr

Net shares bought

−3.0M

by institutions in Q2 2026

New / sold out

9 / 17

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Commodore Capital LP NEW +2.8M
Renaissance Technologies LLC +439.2K

Biggest sellers in Q2 2026

Orbimed Advisors LLC SOLD OUT −3.1M
TCG Crossover Management, LLC SOLD OUT −2.7M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Vistagen Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026

+96.7%

+40.26% a year

Each share's claim on the business

−49.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $10.5M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years24% 1–3 years35% Under 1 year41%

Quarterly turnover

42.0%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting VTGN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
OA Orbimed Advisors LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding3.1M (Q3'25) Change over 8 quarters0 Orbimed Advisors LLC's full portfolio →
CC Commodore Capital LP	2.8M	6.28%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding2.8M (Q2'26) Change over 8 quarters+1.2M Share of the company6.280% Commodore Capital LP's full portfolio →

Orbimed Advisors LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

Commodore Capital LP

2.8M

% of company

6.28%

Change vs last qtr

NEW

Held since

Q2 '26

28 more super investors behind a free account

See every manager holding Vistagen Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting VTGN on Form N-PORT; together they hold 5.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$262K	1.2M	2.61%	0.00%	June 30, 2026
AP AdvisorShares Psychedelics ETF AdvisorShares Trust	$99.1K	438.6K	0.99%	0.22%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$262K

% of company

2.61%

% of the fund

0.00%

As of

June 30, 2026

AdvisorShares Psychedelics ETF

AdvisorShares Trust

Position value

$99.1K

% of company

0.99%

% of the fund

0.22%

As of

June 30, 2026

10 more funds behind a free account

See every fund holding Vistagen Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SS Singh Shawn Insider	99.2K	0.22%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.220% Singh Shawn's insider activity →
AR Adler Reid G. Insider	60.9K	0.14%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.140% Adler Reid G.'s insider activity →

Singh Shawn

Insider

99.2K

% of company

0.22%

Change vs last qtr

—

Held since

—

Adler Reid G.

Insider

60.9K

% of company

0.14%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of Vistagen Therapeutics, Inc..

Comments